Ophthalmology News

Biosimilar medications — drugs developed to be very similar, but not identical, to an FDA-approved biologic — were intended to play a vital role in increasing affordable options for patients struggling with a range of chronic conditions.

For quite a few years now, we have been hearing the same stats about the prevalence and characteristics of dry eye disease patients in the U.S.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Tara A. McCannel, MD, PhD, of UCLA Health in Los Angeles explains the health benefits that acupuncture may offer ophthalmologists.

The COVID-19 pandemic had a great impact on the health care system and the well-being of health care professionals, the effects of which are still felt today.

In this special throwback episode, John Hovanesian, MD, and Jim Mazzo revisit their discussions with Steven Schwartz, MD, and Sean Ianculev, MD, about innovations, treatments and entrepreneurship in eye care.

On this special edition episode, Shikha Jain, MD, with Physicianary’s Hansa Bhargava, MD, and Mend the Gap’s Dagny Zhu, MD, discuss the evolution of empowering yourself and others and advocacy with a panel of guests.

In this video, Barbara Blodi, MD, discusses advancements in gene therapy for the treatment of age-related macular degeneration.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Lisa M. Nijm, MD, JD, discusses the burden of thyroid eye disease and how it affects quality of life.

The FDA cleared an investigational new drug application for OpCT-001, an investigational cell therapy for the treatment of primary photoreceptor diseases, according to a press release from BlueRock Therapeutics.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Zarmeena Vendal, MD, discusses her experience maintaining a private practice in ophthalmology.